- Home
- Equipment
- asia middle east
- risk assessment
Show results for
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- Hong Kong
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Risk Assessment Equipment Supplied In Asia Middle East
10 equipment items found
by:Accruent based inAustin, TEXAS (USA)
Manage attributes of all network connected medical devices. Conduct risk assessments, reconcile MDS2 data and other security attributes against inventory, and remediate potential risks and vulnerabilities. Automate workflows unique to your ...
Manufactured by:Shanghai IVEN Pharmatech Engineering Co., Ltd. based inShanghai, CHINA
The control system incorporates Siemens 300 series PLCs and MP277 touch screens, adhering to GAMP5 standards for automatic control of production, cleaning, and sterilization. The design and verification process includes risk assessment, design confirmation, installation confirmation, and operation confirmation, ensuring comprehensive system ...
Manufactured by:BeamMed Inc. based inPlantation, FLORIDA (USA)
Sunlight MiniOmni and Omnisense™ are currently the only bone sonometers on the market that can measure at multiple skeletal sites. Multi-site testing provides a better chance of identifying individual cases of osteoporosis as well as enabling flexibility in testing patients who cannot be tested at a particular skeletal site. Multi-site measurement also has advantages in monitoring treatment ...
Manufactured by:EGZOTech Sp. z o.o. based inGliwice, POLAND
Riablo is a multisensory therapeutic system that uses biofeedback for professional rehabilitation and assessment of, among others, oncological patients in the area of arms and ...
Manufactured by:KUANG TAI Metal Industrial Company Medical Device Division based inKaohsiung, TAIWAN
Efficient and instant: Two samples can be independently detected simultaneously to instantly understand the patient’s coagulation status and provide suggestions for blood transfusion or fluid infusion. Accurate assessment: Comprehensive assessment of the coagulation function of plasma components and cellular components can be detected to ...
by:Xiamen Spacegen Co., Ltd. based inxiamen, CHINA
Detection Gene:BRCA1, BRCA2 whole exome sequencing and Includes ±20 bp regions at exon-intron junctions. Detection Significance:Predicting prognosis ;Auxiliary diagnosis;Guiding the selection of ...
Manufactured by:Shenzhen Vivolight Medical Device & Technology Co.,Ltd based inBao`an District, CHINA
The Multimodality Optical Coherence Tomography (OCT) System is an advanced intravascular imaging device designed for comprehensive diagnostic capabilities. This system integrates multiple techniques, offering unparalleled and detailed visualization of vascular tissue structures for PCI ...
Manufactured by:Shenzhen Icarelife Bio-Tech Co.,Ltd based inShenzhen, CHINA
ICARELIFE portable negative pressure isolation room specifically designed for instant isolation of patient with suspected or identified infectious diseases that spread via small particles ( such as COVID-19) ...
by:Xiamen Spacegen Co., Ltd. based inxiamen, CHINA
The test kit is based on high-throughput sequencing, covering all common genes related to thyroid tumor typing, prognosis, medication and genetics recommended in NCCN guidelines, CSCO guidelines and expert consensus. DNA level: 16 genes; RNA level: 209 fusion forms of 87 genes. Detection Significance:Predicting prognosis ;Auxiliary diagnosis;Guiding the selection of BRAF/MEK、NTRK、ALK inhibitors ...
by:OncoStem Diagnostics Pvt. Ltd. based inBengaluru, INDIA
CanAssist Breast is a prognostic test developed by OncoStem that classifies the patients as ‘low-risk’ or ‘high-risk’ based on the patient’s risk of breast cancer recurrence over five years. CanAssist Breast provides information about the risk of recurrence of early-stage, hormone ...